OpenNash Jobs
Bausch Health Companies · Bridgewater, NJ

Senior Director Gross-to-Net Forecasting

Bridgewater, New Jersey, USADirectorExecutive & Management

Listed on Bausch Health Companies’s official careers site. Listed as of October 18, 2026. Check that it is still open and apply there.

Apply on Bausch Health Companies’s careers site →

Job description

Join our global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health outcomes to our patients. We are all in it together to make a difference. Be a part of a culture that doesn't just wait for change but actively creates it—where your skills and values drive our collective progress and impact. The Senior Director, Gross-to-Net (GTN) Forecasting is accountable for the leadership, governance, and execution of gross-to-net forecasting and financial reporting for the U.S. pharmaceutical portfolio.

This role oversees GTN forecasting methodologies, helps ensure the accuracy and transparency of reserves, and serves as a senior finance partner to Market Access, Pricing, Accounting, and Commercial leadership. As a key leader within Finance, this position plays a critical role in quarterly forecasts and long-range planning, while driving continuous improvement, automation, data integrity, and analytical insights across GTN processes.

The Senior Director provides thought leadership on GTN risks and opportunities and ensures alignment with financial reporting and compliance standards.

Key Responsibilities

Own and provide executive oversight for the end-to-end GTN forecasting, including rebates, chargebacks, patient assistance programs, returns, Medicaid, and other price concessions. Establish and maintain GTN forecasting standards, methodologies, and governance, ensuring consistency, accuracy, and audit readiness. Serve as the GTN subject matter expert for senior finance leadership, influencing enterprise financial strategy and decision-making.

Direct the development, maintenance, and enhancement of multi-year GTN forecasting models at the product level. Lead in-depth analysis of forecast-to-actual variances, identifying key drivers, trends, and emerging financial risks or opportunities. Assess and communicate the financial impact of pricing strategy changes, contract negotiations, formulary access decisions, benefit design shifts, and market dynamics. Own GTN inputs into annual operating plans, long-range plans, rolling forecasts, and scenario modeling.

Act as a senior finance partner to Market Access, Pricing, Contracting, Legal, and Accounting, providing strategic insight on contract terms and GTN implications. Present GTN performance, risks, and outlooks to CFO leadership, FP&A leadership, and executive stakeholders. Ensure GTN methodologies and estimates align with accounting standards, internal controls, and SOX requirements, partnering closely with Accounting and Internal Audit.

Lead, develop, and mentor a GTN team member, fostering a high-performance, analytical, and collaborative culture. Drive continuous improvement across GTN processes, models, data governance, and systems. Evaluate, prioritize, and lead implementation of automation, advanced analytics, and system enhancements (e.g., forecasting tools, ERP integrations, data visualization platforms).

Qualifications

Bachelors degree required. A minimum of 10 years of progressive experience in finance, forecasting, or accounting, with deep expertise in pharmaceutical Gross-to-Net mechanics. Proven experience operating at a director or senior leadership level, with executive exposure. Deep understanding of U.S. pharmaceutical pricing, payer dynamics, government programs, and contracting structures. Extensive experience with GTN accounting and reserve methodologies.

Advanced financial modeling skills and strong working knowledge of ERP systems (e.g., SAP), GTN forecasting tools, and data analytics. Demonstrated ability to lead and influence cross-functional teams in a matrixed environment. Strong executive presence with the ability to communicate complex financial concepts clearly to senior leaders and non-finance partners. Exceptional analytical rigor, business judgment, and attention to detail, balanced with strategic thinking.

The range of starting base pay for this role is $205K – 282K. Actual starting pay will be based on a wide range of factors including, but not limited to, relevant skills, experience, qualifications, education and location. In addition to base pay, this position is eligible for participation in either (i) our annual bonus program or (ii) a sales incentive plan. Benefits package includes a comprehensive Medical (includes Prescription Drug), Dental, Vision, Flexible Spending Accounts, 401(k) with matching company contribution, discretionary time off, paid sick time, stock purchase plan, tuition reimbursement, parental leave, short-term and long-term disability, life insurance, accidental death & dismemberment insurance, paid holidays, employee referral bonuses and employee discounts.

We are an Equal Opportunity Employer. EOE Disability/Veteran. We are committed to building diverse teams, representative of the patients and communities we serve, and we strive to create an inclusive workplace that cultivates collaboration.

More jobs at Bausch Health Companies

Accounts Payable Administrator

Bridgewater, New Jersey, USA

Director, Medical Affairs, GI & Hepatology

Bridgewater, New Jersey, USA

Inside Sales Representative

Bridgewater, New Jersey, USA

Inventory Manager

Bridgewater, New Jersey, USA

Similar jobs at other companies

Associate Director, Revenue Accounting (Gross to Net)

Teva Pharmaceutical · Parsippany, New Jersey, United States

Senior Director, Mortgage Forecasting & Analytics

Fannie Mae · Washington, District of Columbia

Finance Manager, US IM, Gross-to-Net

Johnson & Johnson · Titusville, New Jersey, United States of America

Oncology Forecasting Manager

GSK · Durham, North Carolina, United States of America

OpenNash lists jobs from employers’ own careers sites and does not handle applications. Dates come from the employer where stated; “first seen” and “last checked” are our own observations.